Lixiang Zhai

机构：Hong Kong Baptist University · ORCID：0000-0002-3907-5910

发表论文 64 篇 · 总被引 1621 次 · h-index 19

代表论文

• Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome (2023 · Nature Communications · 被引 119)
• Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis (2024 · Nature Communications · 被引 35)
• Altered gut microbiota–host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern (2023 · Chinese Medicine · 被引 12)
• Multi-kingdom microbiota analysis reveals bacteria-viral interplay in IBS with depression and anxiety (2025 · npj Biofilms and Microbiomes · 被引 7)
• Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial (2025 · Phytomedicine · 被引 7)
• Gut microbe-derived aromatic trace amines mediate individual variability in response to herbal medicine CDD-2101 for functional constipation (2025 · Pharmacological Research · 被引 6)